| Income Statement | 2025-10-31 | 2025-04-30 | 2024-10-31 | |
|---|---|---|---|---|
| Total revenue | 708 | 491 | 556 | |
| Cost of goods sold | 258 | 208 | 231 | |
| Gross profit | 450 | 283 | 325 | |
| Selling, general and administrative | 743 | 776 | 881 | |
| Research and development | 86 | 91 | 71 | |
| Total operating costs and expenses | 829 | 867 | 952 | |
| Loss from operations | -379 | -584 | -627 | |
| Interest expense, net | 94 | 78 | 62 | |
| Other income, net | 9 | 82 | - | |
| Total other income (expense) | -85 | 4 | -62 | |
| Net loss | -464 | -580 | -689 | |
| Basic net loss per share | 0 | -0.01 | -0.01 | |
| Diluted net loss per share | 0 | -0.01 | -0.01 | |
| Shares used in computing basic net loss per share | 111,886,473 | 111,856,473 | 111,856,473 | |
| Shares used in computing diluted net loss per share | 111,886,473 | 111,856,473 | 111,856,473 | |
PURE BIOSCIENCE, INC. (PURE)
PURE BIOSCIENCE, INC. (PURE)